Carl Zeiss Meditec revenues back to pre-Covid levels in Q1

Carl Zeiss Meditec’s revenues for the first quarter of its 2020/21 financial year reached €368.9 million, down by 0.2 percent year-on-year in reported terms but up by 2.6 percent after adjustment of currency effects. The overall topline recovery was fueled by the good performance of the Ophthalmic Devices’ business unit ...

Keep reading this article by becoming a member


Enjoy unrestricted access to Eyewear Intelligence

To continue reading this article subscribe now

  • Unlimited access to our highly trusted industry insights and analysis
  • Benchmark yourself against the market and competitors
  • Find inspiration to drive your business forward
  • Stay up to date with new business models and startups

If you aren’t ready to subscribe now, you can REGISTER FOR FREE. Already an Eyewear Intelligence subscriber? Sign in here.